Lung Neoplasms
Medicine & Life Sciences
100%
Adenocarcinoma of Lung
Medicine & Life Sciences
58%
Lung
Medicine & Life Sciences
52%
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
50%
Neoplasms
Medicine & Life Sciences
44%
Neoplasm Staging
Medicine & Life Sciences
33%
Adenocarcinoma
Medicine & Life Sciences
30%
Survival
Medicine & Life Sciences
28%
Glass
100%
Lung Neoplasms
82%
Recurrence
59%
Survival
47%
Information Services
41%
Yamanoi, K. ,
Fujii, C. ,
Yuzuriha, H. ,
Kumazawa, M. ,
Shimoda, M. ,
Emoto, K. ,
Asamura, H. &
Nakayama, J. ,
2022 , (Accepted/In press)
In: Histochemistry and Cell Biology. 研究成果: Article › 査読
Acetylglucosamine
100%
Mucinous Adenocarcinoma
98%
Adenocarcinoma of Lung
82%
Polysaccharides
72%
Lung Neoplasms
61%
Suzuki, S. ,
Asakura, K. ,
Okui, M. ,
Sawafuji, M. ,
Shigenobu, T. ,
Tajima, A. ,
Kaseda, K. ,
Masai, K. ,
Hishida, T. &
Asamura, H. ,
2022 , (Accepted/In press)
In: General thoracic and cardiovascular surgery. 研究成果: Article › 査読
Non-Small Cell Lung Carcinoma
100%
Retrospective Studies
75%
Safety
65%
Chemoradiotherapy
35%
Radiotherapy
30%
the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee and Advisory Boards ,
2022 , (Accepted/In press)
In: Journal of Thoracic Oncology. 研究成果: Article › 査読
Neoplasm Staging
100%
Lung Neoplasms
73%
Terminology
31%
Neoplasms
24%
Thorax
21%